Glycine encephalopathy (nonketotic hyperglycinaemia): Review and update

Journal of Inherited Metabolic Disease

Volumn 27, Issue 3, 2004, Pages 417-422

  Applegarth, D A ^a   Toone, J R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; BRAIN DISEASE; DIAGNOSTIC TEST; DISEASE COURSE; HUMAN; HYPERGLYCINEMIA; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRENATAL DIAGNOSIS; PROGNOSIS; REVIEW; WORKSHOP;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HYPERGLYCEMIC HYPEROSMOLAR NONKETOTIC COMA; MICE;

EID: 2942592526     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BOLI.0000031222.38328.59     Document Type: Review

References (16)

1. Aliefendioglu D, Aslan AT, Coskun T, Dursun A, Cakmak FN, Kesimer M (2003) Transient nonketotic hyperglycinemia: two case reports and literature review. Pediatr Neurol 28: 151-155.
2. Applegarth DA, Toone JR, Rolland MO, Black SH, Yim DKC, Bemis G (2000) Non-concordance of CVS and liver glycine cleavage enzyme in 3 families with NKH leading to false negative prenatal diagnosis. Prenat Diagn 20: 367-370.
3. Boneh A, Degani Y, Harani M (1996) Diagnostic clues and outcome of early treatment of NKH. Pediatr Neurol 15: 137-141.
4. Hamosh A, Van Hove JLK (2003) Concerns regarding transience and heterozygosity in neonatal hyperglycinemia. Ann Neurol 53: 685.
5. Hiraga K, Kochi H, Hayasaka K, Kikuchi G, Nyhan WL (1981) Defective glycine cleavage system in non-ketotic hyperglycinemia. J Clin Invest 68: 525-534.
6. Hoover-Fong JE, Shah S, Van Hove JLK, Applegarth DA, Toone JR, Hamosh A (2003) Natural history of glycine encephalopathy in 65 patients. J Inherit Metab Dis 26(2): 64.
7. Ichinohe A, Kojima K, Aoki Y, et al (2003) Seizures and brain malformations in model mice for glycine encephalopathy. J Inherit Metab Dis 26(2): 65.
8. Kojima K, Ichinohe A, Aoki Y, et al (2003) Activity, convulsiveness, aggressiveness, and anxiety in transgenic mice with altered glycine concentrations in central nervous system. J Inherit Metab Dis 26(2): 77.
9. Korman SH, Boneh A, Gutman A, et al (2003) A novel glycine encephalopathy (NKH) variant: absent or transient symptoms but persisting biochemical features. J Inherit Metab Dis 26(2): 66.
10. Kure S, Kojima K, Ichinohe A, et al (2002) Heterozygous GLDC and GCSH gene mutations in transient neonatal hyperglycinemia. Ann Neurol 52: 643-646.
11. Kure S, Kojima K, Ichinohe A, Aoki Y, Suzuki Y, Matsubara Y (2003) A comprehensive mutation analysis of GLDC, AMT, and GCSH in glycine encephalopathy. J Inherit Metab Dis 26(2): 66.
12. Tada K, Kure SJ (1993) Non-ketotic hyperglycinemia: molecular lesion, diagnosis and pathophysiology. J Inherit Metab Dis 16: 691-703.
13. Toone JR, Applegarth DA, Coulter-Mackie MB, James ER (2000) Biochemical and molecular investigations of patients with nonketotic hyperglycinemia (NKH). Mol Genet Metab 70: 116-121.
14. Toone JR, Applegarth DA, Choy F, Coulter-Mackie MB (2003) The Vancouver experience in the diagnosis of glycine encephalopathy (NKH). J Inherit Metab Dis 26(2): 70.
15. Van Hove JLK, Mahieu V, Schollen E, et al (200) Prognosis in nonketotic hyperglycinemia. J Inherit Metab Dis 26(2): 71.
16. Vianey Saban C, Chevalier-Porst F, Froissart R, Rolland MO (2003) Prenatal diagnosis of nonketotic hyperglycinemia: a 13-year experience, from enzymatic to molecular analysis. J Inherit Metab Dis 26(2): 82.